Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q1 2015 · 10-Q
Revenue$211.88K$211.88K+35.3% vs Q1 2014 Net Income-$883.00-$883.00N/M vs Q1 2014 EPS Diluted$0.00$0.00— vs Q1 2014 Gross Profit$119,914+41.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flow-$9,583N/M Free Cash Flowderived-$11,592— Margins · derivedGross margin56.6%+2.6 pt vs Q1 2014
Operating margin0.1%−9.7 pt vs Q1 2014
Net margin-0.4%−9.6 pt vs Q1 2014
ended Mar 31, 2015 · filed Oct 11, 2016 · 560 d after period end